CIPLAMEDICA PHARMACEUTICAL INDUSTRI — Carvedilol Importer Profile
Pharmaceutical Importer · #3 buyer for Carvedilol · $295.2K import value · 14 shipments · YEMEN, DEMOCRATIC · DGFT Verified
CIPLAMEDICA PHARMACEUTICAL INDUSTRI is the #3 importer of Carvedilol from India with $295.2K in import value and 14 verified shipments. CIPLAMEDICA PHARMACEUTICAL INDUSTRI holds a 0.5% market share in Carvedilol imports based in YEMEN, DEMOCRATIC. The company sources from 1 verified supplier across 14 formulations shipped to 2 countries. Overall, CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports 5 pharmaceutical products worth $2.5M across 4 therapeutic categories.
CIPLAMEDICA PHARMACEUTICAL INDUSTRI — Carvedilol Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Carvedilol to CIPLAMEDICA PHARMACEUTICAL INDUSTRI?
Verified from 14 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| CIPLA LIMITED | $295.2K | 14 | 100.0% |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI sources Carvedilol from 1 verified Indian supplier based on 14 customs records. The primary supplier is CIPLA LIMITED accounting for 100.0% of imports.
Where Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import Carvedilol To?
Destination countries from 14 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| YEMEN, DEMOCRATIC | $200.0K | 4 | 67.8% |
| YEMEN | $95.2K | 10 | 32.2% |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports Carvedilol to 2 countries. The primary destination is YEMEN, DEMOCRATIC receiving 67.8% of shipments worth $200.0K.
What Carvedilol Formulations Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import?
| Formulation | Value | Shipments |
|---|---|---|
| CARLOC 6.25 TABLET (CARVEDILOL TABLETS 6.25 MG) (INV.QTY.6720 PACK 10X10S=672000 NOS) | $50.0K | 1 |
| CARLOC 6.25 TABLET (CARVEDILOL TABLETS 6.25 MG) (INV.QTY.6440 PACK 10X10S=644000 NOS) | $50.0K | 1 |
| CARLOC 6.25 TABLET (CARVEDILOL TABLETS 6.25 MG) (INV.QTY.3460 PACK 10X10S=346000 NOS) | $50.0K | 1 |
| CARLOC 6.25 TABLET (CARVEDILOL TABLETS 6.25 MG) (INV.QTY.3163 PACK 10X10S=316300 NOS) | $50.0K | 1 |
| CARLOC 12.5 TABLET CARVEDILOL TABLETS 12.5MG DOCUMENT QTY.2984 PACK 10 X 10S =298400 NOS | $21.1K | 1 |
| CARLOC 25 TABLETS CARVEDILOL TABLETS 25MG INV.QTY.1464 PACK 10X10S=146400 NOS | $13.7K | 1 |
| CARLOC 25 TABLETS CARVEDILOL TABLETS 25MG INV.QTY.980 PACK 10X10S=98000 NOS | $9.1K | 1 |
| CARLOC 25 TABLETS CARVEDILOL TABLETS 25MG INV.QTY.840 PACK 10X10S=84000 NOS | $7.8K | 1 |
| CARLOC 6.25 TABLET CARVEDILOL TABLETS 6.25 MG INV.QTY.2405 PACK 10X10S =240500 NOS | $7.8K | 1 |
| CARLOC 6.25 TABLET CARVEDILOL TABLETS 6.25 MG INV.QTY,2380 PACK 10 X 10S =238000 | $7.7K | 1 |
CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports 14 distinct Carvedilol formulations from India. The top formulation is CARLOC 6.25 TABLET (CARVEDILOL TABLETS 6.25 MG) (INV.QTY.672 with 1 shipments worth $50.0K.
Who Are the Top Buyers of Carvedilol from India and How Much Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Import?
India exported $51.6M worth of Carvedilol through 4,750 shipments from 242 suppliers to 98 countries, serving 529 buyers globally. CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports $295.2K of this total, accounting for 0.5% of India's Carvedilol exports with 14 shipments from YEMEN, DEMOCRATIC. This is verified from 14 customs shipment records covering 14 distinct formulations.
What Is the Average Order Value for CIPLAMEDICA PHARMACEUTICAL INDUSTRI's Carvedilol Imports?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI's average Carvedilol order value is $21.1K per consignment, based on 14 shipments totaling $295.2K. CIPLAMEDICA PHARMACEUTICAL INDUSTRI is based in YEMEN, DEMOCRATIC and ranks #3 among all Carvedilol importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Carvedilol to CIPLAMEDICA PHARMACEUTICAL INDUSTRI?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI sources Carvedilol from 1 verified Indian supplier: CIPLA LIMITED ($295.2K, 100.0%). This is based on 14 customs records.
How Does CIPLAMEDICA PHARMACEUTICAL INDUSTRI Compare to Other Carvedilol Importers?
CIPLAMEDICA PHARMACEUTICAL INDUSTRI ranks #3 among 529 Carvedilol importers from India with a 0.5% market share. The top 3 importers are EVERSANA LIFE SCIENCE SERVICES ($19.3M), GLENMARK PHARMACEUTICALS INC., USA ($6.3M), TEVA PHARMACEUTICALS USA, INC ($5.2M). CIPLAMEDICA PHARMACEUTICAL INDUSTRI processed 14 shipments from YEMEN, DEMOCRATIC.
About CIPLAMEDICA PHARMACEUTICAL INDUSTRI
CIPLAMEDICA PHARMACEUTICAL INDUSTRI imports 5 products worth $2.5M. Beyond Carvedilol, top products include Omeprazole, Pantoprazole, Torsemide, Salicylic. View the complete CIPLAMEDICA PHARMACEUTICAL INDUSTRI profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Carvedilol — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Carvedilol shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: CIPLAMEDICA PHARMACEUTICAL INDUSTRI matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as CIPLAMEDICA PHARMACEUTICAL INDUSTRI's capped import value divided by total capped export value for Carvedilol across all Indian exporters.
- 5.Verified Records: This page is backed by 14 individual customs records matching CIPLAMEDICA PHARMACEUTICAL INDUSTRI importing Carvedilol, covering 14 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 98+ countries, 529+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Carvedilol Import Data for CIPLAMEDICA PHARMACEUTICAL INDUSTRI
Access order-level details, pricing data, supplier connections, and competitive analysis for CIPLAMEDICA PHARMACEUTICAL INDUSTRI's Carvedilol imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
CIPLAMEDICA PHARMACEUTICAL INDUSTRI
Full Company Profile →
5 products · $2.5M total trade · 4 categories
CIPLAMEDICA PHARMACEUTICAL INDUSTRI × Carvedilol
Verified from customs records
Company Overview
Top Products by CIPLAMEDICA PHARMACEUTICAL INDUSTRI
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for CIPLAMEDICA PHARMACEUTICAL INDUSTRI.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Carvedilol. For current order-level data, contact TransData Nexus.